Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2022 Filed Dec 6, 2022 21:32 UTC |
Williams EugeneDirector
|
PurchaseCommon Share | 1,000 | $5.98 | $5,980.00 |
DisclosureSEC source: 0001927626-22-000001 · primary_doc.xml · nonDerivative · entry 1 Williams Eugene · CIK 0001927626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,930 Read SEC document |
| October 11, 2022 Filed Jan 2, 2024 19:45 UTC |
Sclar Jeremy M.10% owner
|
PurchaseWarrants to Purchase Common Shares, no par value · Derivative | 26,217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-000270 · tm2333203-2_4seq1.xml · derivative · entry 5 Sclar Jeremy M. · CIK 0001955608 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By: JS Trust Disclosed balance after: 26,217 Underlying: Common Stock · 26,217 shares Expires not disclosed F8 · derivative.exercise_price: Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023. F8 · price: Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023. F8 · derivative.exercise_date: Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023. F8 · derivative.expiration_date: Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023. F7 · ownership.nature: Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts ("JS Trust"). Mr Sclar's spouse is one of the trustees of the JS Trust. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 20:57 UTC |
Farfel Gail MChief Executive Officer
|
GrantOption (right to buy) · Derivative | 208,334 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001062993-22-019774 · form4.xml · derivative · entry 1 Farfel Gail M · CIK 0001614780 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,334 Underlying: Common Shares · 208,334 shares Expires 2032-09-19 F1 · derivative.exercise_price: Conversion or exercise price is in Canadian dollars. F2 · derivative.exercise_date: The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:05 UTC |
Kirwin Patrick D.Director
|
PurchaseCommon Shares | 4,000 | $5.92 | $23,680.00 |
DisclosureSEC source: 0001062993-22-018369 · form4.xml · nonDerivative · entry 1 Kirwin Patrick D. · CIK 0001927062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,983 F1 · price: The purchase price of CAD$7.65 has been converted to USD based on the Bank of Canada exchange rate on August 17, 2022 of CAD$1.2912= US$1.00. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 16:57 UTC |
Williams EugeneDirector · Chairman and CEO
|
PurchaseCommon Shares | 1,000 | $9.80 | $9,800.00 |
DisclosureSEC source: 0001062993-22-016247 · form4.xml · nonDerivative · entry 1 Williams Eugene · CIK 0001927626 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,930 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.